Sex hormone in younger women could probably help constitute a field of susceptibility to endometriosis and endometrioid cell-type tumors, as well as the recurrence or progression of diseases, which also could account for the phenomenon that younger and premenopausal patients have worse prognosis. The gene discussed is PLXNA3; the disease is endometriosis.